Contact for More Information about the CLR 125 Study for Triple-negative Breast Cancer.

Study Summary
Study Details
Study Therapy
FAQs
Contact Us

Find more information at: Clinicaltrials.gov﻿

NCT: 07311993

If you have any questions about participating in this clinical study, please contact us:

Email: clinical@cellectar.com

If you would like to be contacted by our Study Director, please fill out the form below:

Email

Phone

Thank you!

We have received your submission.

Error

Bad respond

We use cookies to enable essential functionality on our website and analyze website traffic. For more information, read our Cookies and Privacy Policy.

Your Cookie Settings

We use cookies to enable essential functionality on our website and analyze website traffic. For more information, read our Cookies and Privacy Policy.

Cookie Categories

Essential

On

These cookies are strictly necessary to provide you with services available through our websites.

Analytics

On

These cookies collect information that is used in aggregate and in an anonymized form to help us understand how our website is being used and how effectively our site is performing.

Find more information at: Clinicaltrials.gov﻿

If you have any questions about participating in this clinical study, please contact us:

If you would like to be contacted by our Study Director, please fill out the form below:

Find more information at: Clinicaltrials.gov